M&A Deal Summary

Momenta Pharmaceuticals Acquires Virdante Pharmaceuticals - Sialic Switch Assets

On December 5, 2011, Momenta Pharmaceuticals acquired life science company Virdante Pharmaceuticals - Sialic Switch Assets from Virdante Pharmaceuticals for 5M USD

Acquisition Highlights
  • This is Momenta Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Momenta Pharmaceuticals’ largest (disclosed) transaction.
  • This is Momenta Pharmaceuticals’ 2nd transaction in the United States.

M&A Deal Summary

Date 2011-12-05
Target Virdante Pharmaceuticals - Sialic Switch Assets
Sector Life Science
Buyer(s) Momenta Pharmaceuticals
Sellers(s) Virdante Pharmaceuticals
Deal Type Divestiture
Deal Value 5M USD

Target

Virdante Pharmaceuticals - Sialic Switch Assets

United States
Virdante Pharmaceuticals - Sialic Switch assets is a provider of novel therapeutic treatments for autoimmune and inflammatory disorders.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Momenta Pharmaceuticals

Cambridge, Massachusetts, United States

Category Company
Founded 2001
Sector Life Science
Employees131
Revenue 24M USD (2019)
DESCRIPTION

Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis of complex drugs. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications. Momenta Pharmaceuticals was founded in 2001 and is based in Cambridge, Massachusetts.


DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 2 of 2
Year (2011) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-05-10 Parivid

Cambridge, Massachusetts, United States

Parivid LLC is a data integration and analysis services provider.

Buy -

Seller(S) 1

SELLER

Virdante Pharmaceuticals

Cambridge, Massachusetts, United States

Category Company
Founded 2007
Sector Life Science
DESCRIPTION

Virdante Pharmaceuticals, Inc. a pharmaceutical company.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2011) 1 of 1
Size (of disclosed) 1 of 1